Építés alatt – nem éles oldal

Ugrás a tartalomra

Frontlight Research

Vizsgálati helyszín

Minnesota Oncology - Coon Rapids

Coon Rapids, Minnesota 55433, Egyesült ÁllamokMég nincs intézményhez kötve

22futó vizsgálat
1lezárt vizsgálat

Az itteni vizsgálatok

Miről szól a helyszín 23 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek: Vastagbélrák6 vizsgálat
Tüdőrák5 vizsgálat
Mielóma multiplex4 vizsgálat
Petefészekrák4 vizsgálat
Gyomor- és nyelőcsőrák3 vizsgálat
Hólyagrák2 vizsgálat
Prosztatarák2 vizsgálat
Akut limfoid leukémia (ALL)1 vizsgálat
Akut mieloid leukémia (AML)1 vizsgálat
Áttétes emlőrák1 vizsgálat
Fej-nyaki daganatok1 vizsgálat
Gyermekkori daganatok1 vizsgálat
és még 7
Fázis: 3. fázis10 vizsgálat
2. fázis3 vizsgálat
2/3. fázis2 vizsgálat
Állapot: Toboroz19 vizsgálat
Fut, nem toboroz3 vizsgálat
Leállították1 vizsgálat
Fő szponzor: NRG Oncology7 vizsgálat
Alliance for Clinical Trials in Oncology6 vizsgálat
ECOG-ACRIN Cancer Research Group6 vizsgálat
National Cancer Institute (NCI)1 vizsgálat
Strata Oncology1 vizsgálat
és még 2

Futó vizsgálatok

Toboroz
Family Communications After Genetic Testing
NCT07143487· Alliance for Clinical Trials in Oncology· Forrás
Contact: Yan Ji (principal investigator)
Toboroz
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
NCT07283939· Alliance for Clinical Trials in Oncology· Forrás
Contact: Margaret B. Nolan (principal investigator)
Toboroz
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
NCT07097142· 3. fázis· NRG Oncology· Forrás
Contact: Charles Shideman (principal investigator)
Toboroz
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
NCT06580314· 3. fázis· NRG Oncology· Forrás
Contact: Jessica A. Thomes Pepin (principal investigator)
Toboroz
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
NCT06475989· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás
Contact: David M. King (principal investigator)
Fut, nem toboroz
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
NCT06632327· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás
Toboroz
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
NCT06295367· ECOG-ACRIN Cancer Research Group· Forrás
Contact: Margaret B. Nolan (principal investigator)
Toboroz
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
NCT05879926· 3. fázis· NRG Oncology· Forrás
Contact: Joleen M. Hubbard (principal investigator)
Toboroz
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
NCT05677490· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás
Contact: Yan Ji (principal investigator)
Toboroz
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069· Alliance for Clinical Trials in Oncology· Forrás
Contact: Yan Ji (principal investigator)
Toboroz
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
NCT05174169· 2/3. fázis· NRG Oncology· Forrás
Contact: Joleen M. Hubbard (principal investigator)
Toboroz
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NCT05080673· NRG Oncology· Forrás
Contact: Yan Ji (principal investigator)
Fut, nem toboroz
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
NCT04804644· 3. fázis· NRG Oncology· Forrás
Toboroz
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
NCT04566328· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás
Contact: David M. King (principal investigator)
Toboroz
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
NCT04423211· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás
Contact: David M. King (principal investigator)
Toboroz
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NCT04251052· NRG Oncology· Forrás
Contact: Jessica A. Thomes Pepin (principal investigator)
Toboroz
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
NCT03998202· Wake Forest University Health Sciences· Forrás
Contact: Karen Craver
Toboroz
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
NCT03937635· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás
Contact: David M. King (principal investigator)
Toboroz
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
NCT03851445· 2/3. fázis· SWOG Cancer Research Network· Forrás
Contact: David M. King (principal investigator)
Toboroz
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
NCT03191149· 2. fázis· National Cancer Institute (NCI)· Forrás
Contact: David M. King (principal investigator)
Toboroz
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
NCT02734537· 2. fázis· ECOG-ACRIN Cancer Research Group· Forrás
Contact: David M. King (principal investigator)
Toboroz
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
NCT02523014· 2. fázis· Alliance for Clinical Trials in Oncology· Forrás
Contact: Yan Ji (principal investigator)

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Lezárt vizsgálatok

Leállították
Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
NCT03061305· Strata Oncology· Forrás

Helyszínadatok: ClinicalTrials.govFrissítve: 2026. nov. 14.

Építés alatt, nem éles – Minnesota Oncology - Coon Rapids: vizsgálati helyszín – Frontlight Research